TPG buys Actavis' contracting firm; Novella staffed up since Quintiles buyout;

> TPG closed its acquisition of Aptalis, Actavis' ($ACT) in-house R&D outsourcing company, rechristening it Adare Pharma. News

> IPCA Laboratories' Onyx Scientific is expanding its API manufacturing operation in the U.K. More

> Novella Clinical has added about 90 employees since Quintiles ($Q) bought it for $147 million in 2013. Item

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.